|
FY2020
12 months to Dec 31, 2020
|
FY2019
12 months to Dec 31, 2019
|
FY2018
12 months to Dec 31, 2018
|
FY2017
12 months to Dec 31, 2017
|
FY2016
12 months to Dec 31, 2016
|
|
|---|---|---|---|---|---|
| OPERATING ACTIVITIES: | |||||
| Net (loss) income | |||||
| Adjustments to reconcile net income from continuing operations to net cash provided by operating activities from continuing operations: | |||||
| Depreciation, Amortization and Accretion, Net | |||||
| Amortization of long-term debt deferred financing costs | |||||
| (Loss) gain on asset sales | |||||
| Impairment charges | |||||
| Loss on extinguishment of debt | |||||
| Provision for expected credit losses | |||||
| Stock-based compensation expense | |||||
| Equity in net income from unconsolidated investments | |||||
| Increase (Decrease) in Deferred Income Taxes | |||||
| SEC Schedule, 12-04, Cash Dividends Paid to Registrant, 50 Percent or Less Owned Persons | |||||
| Other, net | |||||
| Change in operating assets and liabilities, net of effects of acquisitions: | |||||
| Receivables | |||||
| Increase (Decrease) in Prepaid Expense and Other Assets | |||||
| Accounts payable and accrued expenses | |||||
| Net cash provided by operating activities | |||||
| INVESTING ACTIVITIES: | |||||
| Payments to Acquire Productive Assets | |||||
| Acquisition of businesses, net of cash acquired | |||||
| Proceeds from Sale of Other Assets, Investing Activities | |||||
| Proceeds from Insurance Settlement, Investing Activities | |||||
| Loss Contingency Accrual, Payments | |||||
| Investment in equity affiliate | |||||
| Other, net | |||||
| Net cash used in investing activities | |||||
| FINANCING ACTIVITIES: | |||||
| Proceeds from borrowings on long-term debt | |||||
| Proceeds from borrowings on revolving credit facility | |||||
| Proceeds from equipment financing capital lease | |||||
| Proceeds from borrowings on Dublin project financing | |||||
| Proceeds from settlement of Note Hedge | |||||
| Payments related to cash conversion option | |||||
| Proceeds from insurance premium financing | |||||
| Principal payments on long-term debt | |||||
| Payments of borrowings on revolving credit facility | |||||
| Principal payments on project debt | |||||
| Payments of deferred financing costs | |||||
| DublinFinancing | |||||
| Total payments of deferred financing costs | |||||
| Cash dividends paid to stockholders | |||||
| Common stock repurchased | |||||
| Payments For Insurance Premium | |||||
| Proceeds from Related Party Debt | |||||
| Other, net | |||||
| Net cash used in financing activities | |||||
| Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Net increase (decrease) in cash, cash equivalents and restricted cash | |||||
| Less: Cash and cash equivalents of assets held for sale and discontinued operations at end of period | |||||
| Cash and cash equivalents | |||||
| Restricted funds held in trust | |||||
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | |||||
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | |||||
| Cash Paid for Interest and Income Taxes: | |||||
| Interest Paid, Excluding Capitalized Interest, Operating Activities | |||||
| Cash Paid of Income taxes, net of refunds | |||||
Loading...